![]() |
|||
![]() |
CoQ10 (Coenzyme Q10)is found in virtually all cells of human body, including the heart, liver, and skeletal muscles. It functions as a carrier to transfer electrons across the membrane of mitochondria (the energy generator in the body's cells) to drive the production of adenosine triphosphate (ATP), the fuel that energizes cells in our body. Heart muscle cells have the greatest concentration of mitochondria, 5,000 per cell. It also possesses antioxidant and membrane-stabilizing properties. Coenzyme Q10 from supplements, ubiquinone, must first be reduced to ubiquinol to act as an antioxidant. As an antioxidant, it can protect proteins, LDL-cholesterol (bad cholesterol), and mitochondrial DNA from oxidative damage. Because of its function in the production of cellular energy, and as an antioxidant, Coenzyme Q10 can aid in the body's response to a host of health problems including heart disease, cancer, aging, neuro-degenerative diseases, and muscular dystrophy. CoQ10 is comprised of a quinone ring and a side chain consisting of ten repeating 5-carbon isoprene units. Because of its structure, it is highly lipophilic and practically insoluble in water. This lipophilic nature also affects bioavailability, making its absorption poor. Crystals are formed when it is produced commercially. The size of Coenzyme Q10 crystals and degree of solubility of Coenzyme Q10 in a solvent will likely affect the bioavailability of it. CoQsol-CF is a unique, patent-pending formula of Coenzyme Q10, food grade d-limonene (which serves as a non-polar, organic solvent), and tocopherol (vitamin E). This combination created a liquid, Crystal-free solution of CoQ10 that provides enhanced bioavailability. By improving dissolution, absorption is enhanced.
Why People Use It Heart failure Cardiomyopathy Heart Attack Prevention and Recovery High Blood Pressure Diabetes Gum Disease Kidney Failure Migraine Counteract Prescription Drug Effects Parkinson's disease Weight loss
In a pilot clinical trial involving five normal volunteers (3 men and 2 women), the peak absorption characteristics and steady state bioavailability of CoQsol-CFT were determined. The mean control plasma level was established to be 0.88 µg/ml. On the first day of the study, volunteers took 60 mg CoQsol-CFT, within four hours after ingesting the Coenzyme Q 10, the plasma levels increased significantly to 1.36 µg/ml. Volunteers continued taking 60 mg CoQsol-CFT daily for 28 days. At the 28th day, the mean plasma Coenzyme Q 10 level was 2.75µg/ml. This means that in this steady state study, the mean Coenzyme Q 10 plasma level increased by 200%. There are numerous published studies indicating a potential benefit from the use of CoQ10; and CoQsol-CFT is a breakthrough formulation that provides maximum solubility for increased bioavailability. For a more complete discussion of CoQsol-CFT, please visit the featured product section of our web site or take our product training course featured on
Lower levels of CoQ10 have also been observed in people with Parkinson's disease. Preliminary research has found that increasing it may increase levels of the neurotransmitter dopamine, which is thought to be lowered in people with Parkinson's disease. It has also been suggested that it might protect brain cells from damage by free radicals.
A Gentle Cancer Killer Researchers have found that CoQ10, an antioxident that occurs naturally in the body, could become a powerful weapon in the fight against certain cancers.
Custom Search
If pregnant, nursing or using prescription drugs, consult with yoru physician
|
||